Report Overview

The US Hepatitis A market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Hepatitis A is a liver disease caused by hepatitis A virus that can lead to mild to severe illness. The hepatitis A virus (HAV) is spread through direct contact with an infectious person or through ingestion of contaminated food and water. Most patients recover fully from hepatitis A with a lifelong immunity. However, a small number of people with hepatitis A could succumb to the disease. The hepatitis A virus is one of the common reasons for foodborne infection. According to the U.S. Department of Health and Human Services, hepatitis A is a vaccine-preventable, communicable disease of the liver caused by the hepatitis A virus (HAV). Antibodies produced in response to hepatitis A infection last through life and protect against recurrence of infection



Market Drivers

In 2015 and 2016, the reported cases again increased by 44.4% from 1,390 in 2015 to 2,007 cases in 2016. The 2016 increase was due to two hepatitis A outbreaks, each of which was linked to imported foods. Substantial increases in incident cases of hepatitis A occurred in 2017 and 2018 3,366 and 12,474 reported cases, respectively due to ongoing outbreaks reported to CDC among people who use drugs and people which are homeless as well as outbreaks among men who have sex with men

Thehepatitis Acase-fatality rateamong persons of all ages with reported cases was approximately 0.3% but may have been higher among older persons (approximately 2% among persons 40 years of age and older) More recent case-fatalityestimates range from 0.3%-0.6% for all ages and up to 1.8% among adults aged >50 years

Epidemiology of Hepatitis A virus

Hepatitis A incidence compared to healthy people in 2020 in United States 2016



 

Of the 50 reporting states, 18 (36%) met the Healthy People 2020 goal of reducing hepatitis A incidence to 0.3 cases/100,000 population: Alaska, Delaware, Indiana, Kansas, Kentucky, Louisiana, Minnesota, Mississippi, Missouri, Montana, New Mexico, North Dakota, Ohio, Oklahoma, South Dakota, Tennessee, Wisconsin, and Wyoming.
The incidence of hepatitis A was above the Healthy People 2020 goal for 32 states and the District of Columbia: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Maine, Maryland, Massachusetts, Michigan, Nebraska,
Nevada, New Hampshire, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Virginia, Washington, and West Virginia. Of the 32 states with rates above the Healthy People 2020 goal, eight states Hawaii, Massachusetts, Michigan, Nebraska, New Jersey, Vermont, Virginia, and West Virginia had rates more than twice the national goal